Association of total VLDL particle concentrations with elevated blood viscosity in patients with type 2 diabetes

Author(s):  
Robert S. Rosenson ◽  
Martin L. Lee ◽  
Qinzhong Chen
2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Miira Klemetti ◽  
Leena M. Hiltunen ◽  
Sanna Heino ◽  
Seppo Heinonen ◽  
Eero Kajantie ◽  
...  

Previous studies have demonstrated a common variant of the obesity and fat mass-relatedFTOgene, rs9939609, to be associated with obesity, type 2 diabetes, and elevated blood pressure. We investigated whether theFTOSNP rs9939609 is associated with the risk of preeclampsia (PE) in a Finnish study population. 485 women with prior PE and 449 women who had given birth after a normotensive pregnancy were genotyped (TaqMan) for the SNP rs9939609. The prevalences of genotypes AA, AT, and TT were 15%, 53%, and 32%, respectively, among the PE cases, and 16%, 47%, and 37%, respectively, among the controls (P=0.199). We found no evidence of an association between theFTOSNP rs9939609 and PE. However, our cases were dominated by severe, early-onset PE. Thus, we are unable to exclude an association with the milder, later-onset form of the disease in which the role of maternal metabolic predisposition could be more significant.Erratum to “An Obesity-RelatedFTOVariant and the Risk of Preeclampsia in a Finnish Study Population”


2020 ◽  
Vol 13 (11) ◽  
pp. 410
Author(s):  
Malcolm J. Borg ◽  
Christopher K. Rayner ◽  
Karen L. Jones ◽  
Michael Horowitz ◽  
Cong Xie ◽  
...  

Metformin, the most widely prescribed drug therapy for type 2 diabetes, has pleiotropic benefits, in addition to its capacity to lower elevated blood glucose levels, including mitigation of cardiovascular risk. The mechanisms underlying the latter remain unclear. Mechanistic studies have, hitherto, focused on the direct effects of metformin on the heart and vasculature. It is now appreciated that effects in the gastrointestinal tract are important to glucose-lowering by metformin. Gastrointestinal actions of metformin also have major implications for cardiovascular function. This review summarizes the gastrointestinal mechanisms underlying the action of metformin and their potential relevance to cardiovascular benefits.


2007 ◽  
Vol 18 (8) ◽  
pp. 745-750 ◽  
Author(s):  
Ludovico Coppola ◽  
Teresa Cerciello ◽  
Paraskevula Boviatsi ◽  
Agostino Pastore ◽  
Antonino Coppola ◽  
...  

2010 ◽  
Vol 95 (1) ◽  
pp. 94-98 ◽  
Author(s):  
C. Irace ◽  
F. Scarinci ◽  
V. Scorcia ◽  
D. Bruzzichessi ◽  
R. Fiorentino ◽  
...  

2018 ◽  
Vol 17 (1) ◽  
Author(s):  
Concetta Irace ◽  
Francesco Casciaro ◽  
Faustina Barbara Scavelli ◽  
Rosa Oliverio ◽  
Antonio Cutruzzolà ◽  
...  

2019 ◽  
Vol 148 ◽  
pp. 43-53 ◽  
Author(s):  
Ali Noori-Zadeh ◽  
Salar Bakhtiyari ◽  
Shokoufeh Khanjari ◽  
Karimeh Haghani ◽  
Shahram Darabi

Sign in / Sign up

Export Citation Format

Share Document